JP2019521659A5 - - Google Patents

Download PDF

Info

Publication number
JP2019521659A5
JP2019521659A5 JP2018561967A JP2018561967A JP2019521659A5 JP 2019521659 A5 JP2019521659 A5 JP 2019521659A5 JP 2018561967 A JP2018561967 A JP 2018561967A JP 2018561967 A JP2018561967 A JP 2018561967A JP 2019521659 A5 JP2019521659 A5 JP 2019521659A5
Authority
JP
Japan
Prior art keywords
genome editing
editing complex
complex according
peptide
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018561967A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019521659A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/034862 external-priority patent/WO2017205846A1/en
Publication of JP2019521659A publication Critical patent/JP2019521659A/ja
Publication of JP2019521659A5 publication Critical patent/JP2019521659A5/ja
Priority to JP2021184056A priority Critical patent/JP7379447B2/ja
Priority to JP2023169638A priority patent/JP2023165986A/ja
Priority to JP2025079827A priority patent/JP2025118829A/ja
Pending legal-status Critical Current

Links

JP2018561967A 2016-05-27 2017-05-26 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子 Pending JP2019521659A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021184056A JP7379447B2 (ja) 2016-05-27 2021-11-11 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2023169638A JP2023165986A (ja) 2016-05-27 2023-09-29 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2025079827A JP2025118829A (ja) 2016-05-27 2025-05-12 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662342823P 2016-05-27 2016-05-27
US62/342,823 2016-05-27
US201662394140P 2016-09-13 2016-09-13
US62/394,140 2016-09-13
US201762477357P 2017-03-27 2017-03-27
US62/477,357 2017-03-27
PCT/US2017/034862 WO2017205846A1 (en) 2016-05-27 2017-05-26 Peptides and nanoparticles for intracellular delivery of genome-editing molecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021184056A Division JP7379447B2 (ja) 2016-05-27 2021-11-11 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子

Publications (2)

Publication Number Publication Date
JP2019521659A JP2019521659A (ja) 2019-08-08
JP2019521659A5 true JP2019521659A5 (enExample) 2020-07-02

Family

ID=59239942

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018561967A Pending JP2019521659A (ja) 2016-05-27 2017-05-26 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2021184056A Active JP7379447B2 (ja) 2016-05-27 2021-11-11 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2023169638A Withdrawn JP2023165986A (ja) 2016-05-27 2023-09-29 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2025079827A Pending JP2025118829A (ja) 2016-05-27 2025-05-12 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021184056A Active JP7379447B2 (ja) 2016-05-27 2021-11-11 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2023169638A Withdrawn JP2023165986A (ja) 2016-05-27 2023-09-29 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
JP2025079827A Pending JP2025118829A (ja) 2016-05-27 2025-05-12 ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子

Country Status (9)

Country Link
EP (2) EP3464323B1 (enExample)
JP (4) JP2019521659A (enExample)
CN (2) CN117431234A (enExample)
AU (2) AU2017268842B2 (enExample)
CA (1) CA3025523A1 (enExample)
ES (1) ES2901215T3 (enExample)
MX (2) MX388294B (enExample)
WO (1) WO2017205846A1 (enExample)
ZA (1) ZA201807869B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020530463A (ja) * 2017-08-10 2020-10-22 アーディジェン， エルエルシー ウイルスの細胞内送達のためのペプチドおよびナノ粒子
JP7395483B2 (ja) * 2017-10-16 2023-12-11 アーディジェン， エルエルシー ｍＲＮＡの細胞内送達のためのペプチドおよびナノ粒子
FR3081169B1 (fr) * 2018-05-15 2020-06-19 Messenger Biopharma Substitution de la coiffe des arn messagers par deux sequences d'arn introduites a leur extremite 5'
WO2019237384A1 (zh) * 2018-06-16 2019-12-19 深圳市博奥康生物科技有限公司 用于敲除人CDw137基因的gRNA序列及其应用
WO2019237387A1 (zh) * 2018-06-16 2019-12-19 深圳市博奥康生物科技有限公司 用于敲除人ACT35基因的gRNA序列及其应用
CN111363013B (zh) * 2018-12-25 2021-11-19 深圳先进技术研究院 多组分纳米颗粒簇的构建方法
CN113543797A (zh) * 2019-01-04 2021-10-22 芝加哥大学 用于调节rna的系统和方法
GB201902648D0 (en) 2019-02-27 2019-04-10 Cyca Oncosolutions Ltd Cell membrane penetrating conjugates
WO2020214846A1 (en) * 2019-04-17 2020-10-22 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of molecules
CN109880891B (zh) * 2019-04-22 2021-07-30 上海交通大学 基于核酸酶偶联pcr原理富集低丰度dna突变的检测技术体系及应用
EP3966326A1 (en) * 2019-05-07 2022-03-16 Ecole Polytechnique Federale De Lausanne (Epfl) Fmrp and cancer treatment
CN110638789A (zh) * 2019-10-31 2020-01-03 南开大学 一种可实现肿瘤靶向递送核糖核蛋白复合物的纳米粒子的制备方法和应用
US20230167437A1 (en) * 2020-04-24 2023-06-01 Aadigen, Llc Compositions for treating cancer with kras mutations and uses thereof
EP4185602A1 (en) * 2020-07-24 2023-05-31 Aadigen, LLC Compositions and methods for treating viral infections
KR102500873B1 (ko) * 2021-02-03 2023-02-17 한국과학기술연구원 자연살해세포 특이적 CRISPR/Cas 시스템을 위한 융합 단백질 및 이의 용도
EP4377472A2 (en) * 2021-07-26 2024-06-05 Imperial College Innovations Limited Nanozyme-catalysed detection of nucleic acids
EP4777526A1 (en) 2023-09-12 2026-07-22 Aadigen, LLC Methods and compositions for treating or preventing cancer
WO2025090926A1 (en) * 2023-10-26 2025-05-01 The Penn State Research Foundation Ultrasound-sensitive peptide particles with surface-bound gene editing tools for spatially resolved molecule delivery
CN119119204B (zh) * 2024-11-11 2025-03-18 南昌大学 温敏特异性多肽和基于温差特异性无损分离外泌体的方法

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436150A (en) 1992-04-03 1995-07-25 The Johns Hopkins University Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
US5356802A (en) 1992-04-03 1994-10-18 The Johns Hopkins University Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
US5487994A (en) 1992-04-03 1996-01-30 The Johns Hopkins University Insertion and deletion mutants of FokI restriction endonuclease
AU5600194A (en) 1992-11-13 1994-06-08 Winalee G. Mitchell Absorbent including super absorbent and capacity monitor
JPH11506722A (ja) 1995-06-07 1999-06-15 ベイラー・カレッジ・オブ・メディスン 細胞に核酸を送達するための核酸運搬体
US6451995B1 (en) 1996-03-20 2002-09-17 Sloan-Kettering Institute For Cancer Research Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods
WO2000014257A1 (en) 1998-09-04 2000-03-16 Sloan-Kettering Institute For Cancer Research Fusion receptors specific for prostate-specific membrane antigen and uses thereof
AU2472400A (en) 1998-10-20 2000-05-08 City Of Hope CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US6503717B2 (en) 1999-12-06 2003-01-07 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US7070934B2 (en) 1999-01-12 2006-07-04 Sangamo Biosciences, Inc. Ligand-controlled regulation of endogenous gene expression
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
AU2001250774B2 (en) 2000-02-08 2005-01-27 Sangamo Biosciences, Inc. Cells expressing zinc finger proteins for drug discovery
CA2410510A1 (en) 2000-06-02 2001-12-13 Memorial Sloan-Kettering Cancer Center Artificial antigen presenting cells and methods of use thereof
US7446179B2 (en) 2000-11-07 2008-11-04 City Of Hope CD19-specific chimeric T cell receptor
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7070995B2 (en) 2001-04-11 2006-07-04 City Of Hope CE7-specific redirected immune cells
US20090257994A1 (en) 2001-04-30 2009-10-15 City Of Hope Chimeric immunoreceptor useful in treating human cancers
US7262054B2 (en) 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
US7446190B2 (en) 2002-05-28 2008-11-04 Sloan-Kettering Institute For Cancer Research Nucleic acids encoding chimeric T cell receptors
US7361635B2 (en) 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes
US20050129671A1 (en) 2003-03-11 2005-06-16 City Of Hope Mammalian antigen-presenting T cells and bi-specific T cells
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
ATE418346T1 (de) 2004-04-08 2009-01-15 Sangamo Biosciences Inc Zusammensetzungen zur behandlung von neuropathischen und neurodegenerativen erkrankungen
US7253273B2 (en) 2004-04-08 2007-08-07 Sangamo Biosciences, Inc. Treatment of neuropathic pain with zinc finger proteins
US7514530B2 (en) 2004-04-26 2009-04-07 Centre National De La Recherche Scientifique Peptide carrier for delivering siRNA into mammalian cells
US7579318B2 (en) 2005-12-06 2009-08-25 Centre De La Recherche De La Scientifique Cell penetrating peptides for intracellular delivery of molecules
US8389282B2 (en) 2007-03-30 2013-03-05 Memorial Sloan-Kettering Cancer Center Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
US8479118B2 (en) 2007-12-10 2013-07-02 Microsoft Corporation Switching search providers within a browser search box
JP5173594B2 (ja) 2008-05-27 2013-04-03 キヤノン株式会社 管理装置、画像形成装置及びそれらの処理方法
DE102008036364A1 (de) 2008-08-05 2010-02-18 Khs Ag Verfahren zum Herstellen von Behälterzellen
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
US8889394B2 (en) 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
AU2011256838B2 (en) 2010-05-17 2014-10-09 Sangamo Therapeutics, Inc. Novel DNA-binding proteins and uses thereof
PH12013501201A1 (en) 2010-12-09 2013-07-29 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
WO2012129514A1 (en) 2011-03-23 2012-09-27 Fred Hutchinson Cancer Research Center Method and compositions for cellular immunotherapy
WO2012137036A1 (en) 2011-04-04 2012-10-11 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
US8398282B2 (en) 2011-05-12 2013-03-19 Delphi Technologies, Inc. Vehicle front lighting assembly and systems having a variable tint electrowetting element
WO2013071154A1 (en) 2011-11-11 2013-05-16 Fred Hutchinson Cancer Research Center Cyclin a1-targeted t-cell immunotherapy for cancer
EP2814846B1 (en) 2012-02-13 2020-01-08 Seattle Children's Hospital d/b/a Seattle Children's Research Institute Bispecific chimeric antigen receptors and therapeutic uses thereof
WO2013126726A1 (en) 2012-02-22 2013-08-29 The Trustees Of The University Of Pennsylvania Double transgenic t cells comprising a car and a tcr and their methods of use
NZ702108A (en) 2012-05-03 2016-09-30 Hutchinson Fred Cancer Res Enhanced affinity t cell receptors and methods for making the same
ES2728782T3 (es) * 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
LT2884999T (lt) 2012-08-20 2021-04-12 Fred Hutchinson Cancer Research Center Ląstelinės imunoterapijos būdas ir kompozicijos
RU2729401C2 (ru) 2012-10-02 2020-08-06 Мемориал Слоан-Кеттеринг Кэнсер Сентер Композиции и способы для иммунотерапии
WO2014053879A1 (en) * 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2014053882A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2014053881A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
WO2014053880A1 (en) 2012-10-04 2014-04-10 Centre National De La Recherche Scientifique Cell penetrating peptides for intracellular delivery of molecules
EP4397759A3 (en) * 2012-10-23 2024-10-09 Toolgen Incorporated Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
CN106133138A (zh) 2013-08-22 2016-11-16 先锋国际良种公司 使用引导多核苷酸/cas内切核酸酶系统的基因组修饰及其使用方法
US9526784B2 (en) * 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
JP2016539653A (ja) * 2013-12-13 2016-12-22 セレクティス 微小藻類のゲノム操作のためのＣａｓ９ヌクレアーゼプラットフォーム
DK3597740T3 (da) * 2014-11-06 2022-06-20 Dupont Us Holding Llc Peptidmedieret indføring af rna-styret endonuklease i celler
EP3237436B1 (en) 2014-12-24 2019-05-01 Aadigen, Llc Peptides and nanoparticles for intracellular delivery of molecules

Similar Documents

Publication Publication Date Title
ES2743188T3 (es) Péptidos y nanopartículas para el suministro intracelular de moléculas
US20200095605A1 (en) Compositions and methods for nucleic acid and/or protein payload delivery
US10377998B2 (en) CRISPR-CAS systems and methods for altering expression of gene products, structural information and inducible modular CAS enzymes
US20230323401A1 (en) Methods and compositions for genome editing
AU2024202093A1 (en) Peptides and nanoparticles for intracellular delivery of mrna
Lin et al. Chemical evolution of amphiphilic xenopeptides for potentiated Cas9 ribonucleoprotein delivery
JP7471289B2 (ja) 抗ｌｉｖ１免疫細胞癌療法
JP2024122981A (ja) ゲノム編集方法及び組成物
JP2026005238A (ja) Ｋｒａｓ突然変異を有するがんを処置するための組成物およびその使用
US20250101425A1 (en) Nanoparticles functionalized with gene editing tools and related methods
WO2020223705A2 (en) Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents
JP2026500040A (ja) 複合体及びその使用
JP2025518552A (ja) 細胞を操作するための組成物及び方法
US12584145B2 (en) Conjugate systems and methods of use thereof
JP2023031025A (ja) 小胞分泌制御剤および小胞取り込み制御剤